Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Barry

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in IrelandHelen O'Donnell, Felicity Lamrock, Lesley Tilson, et al.
Pharmacoeconomics|August 4, 2017
Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for CancerLaura McCullagh, Susanne Schmitz, Michael Barry, et al.
Physical Review Letters|August 23, 2014
Failed escape: solid surfaces prevent tumbling of Escherichia coliMehdi Molaei, Michael Barry, Roman Stocker, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 2, 2020
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in IrelandFelicity Lamrock, Laura McCullagh, Lesley Tilson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
The high cost of medicines in Ireland. Is it time to change the pricing mechanism?Lesley Tilson, Bernadette McGowan, Kathleen Bennett, et al.
Pharmacoeconomics|March 13, 2010
Pharmacoeconomic evaluation in Ireland: a review of the processLesley Tilson, Aisling O'Leary, Cara Usher, et al.
Journal of Health Care Chaplaincy|May 3, 2014
Restore: the journey toward self-forgiveness: a randomized trial of patient education on self-forgiveness in cancer patients and caregiversLoren Toussaint, Michael Barry, Lynn Bornfriend, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 19, 2010
Health Technology Assessment International 7th Annual Meeting: Dublin, Ireland, 6–9 June 2010Emer Fogarty, Lesley Tilson, Máirín Ryan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluationAdrienne Heerey, Bernie McGowan, Mairin Ryan, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 4, 2020
The Interaction between Price Negotiations and Heterogeneity: Implications for Economic EvaluationsHelen O'Donnell, Laura McCullagh, Michael Barry, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in IrelandHelen O'Donnell, Felicity Lamrock, Lesley Tilson, et al.
Pharmacoeconomics|August 4, 2017
Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for CancerLaura McCullagh, Susanne Schmitz, Michael Barry, et al.
Physical Review Letters|August 23, 2014
Failed escape: solid surfaces prevent tumbling of Escherichia coliMehdi Molaei, Michael Barry, Roman Stocker, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 2, 2020
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in IrelandFelicity Lamrock, Laura McCullagh, Lesley Tilson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
The high cost of medicines in Ireland. Is it time to change the pricing mechanism?Lesley Tilson, Bernadette McGowan, Kathleen Bennett, et al.
Pharmacoeconomics|March 13, 2010
Pharmacoeconomic evaluation in Ireland: a review of the processLesley Tilson, Aisling O'Leary, Cara Usher, et al.
Journal of Health Care Chaplaincy|May 3, 2014
Restore: the journey toward self-forgiveness: a randomized trial of patient education on self-forgiveness in cancer patients and caregiversLoren Toussaint, Michael Barry, Lynn Bornfriend, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 19, 2010
Health Technology Assessment International 7th Annual Meeting: Dublin, Ireland, 6–9 June 2010Emer Fogarty, Lesley Tilson, Máirín Ryan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluationAdrienne Heerey, Bernie McGowan, Mairin Ryan, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 4, 2020
The Interaction between Price Negotiations and Heterogeneity: Implications for Economic EvaluationsHelen O'Donnell, Laura McCullagh, Michael Barry, et al.
Pageof 16